75 crore Covid vaccine doses administered; WHO hails feat

New Delhi: India has crossed the landmark of administering 75 crore Covid-19 vaccine doses, Union Health Minister Mansukh Mandaviya said Monday.

More than 71 lakh doses were administered on Monday till 7 PM, according to the provisional data available on the Co-WIN portal. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late night, the ministry said.

According to the 7 pm provisional data available on the portal, over 57 crore people have been vaccinated with the first dose and more than 18 crore with their second. The country has also jabbed more than 99 per cent healthcare workers (HCWs) and frontline workers (FLWs ) with at least one shot of Covid-19 vaccine, it said.

Mandaviya said the country’s vaccination drive continues to achieve new dimensions of success under the leadership of Prime Minister Narendra Modi and with his mantra of “Sabka Saath, Sabka Prayas (together with everybody, with everybody’s efforts”. “Congratulations India! In the 75th year of independence, the country has crossed the figure of 75 crore vaccinations,” the health minister tweeted with hashtags #SabkoVaccineMuftVaccine and #AazadiKaAmritMahotsav.

The WHO’s southeast Asia office also lauded India for accelerating Covid-19 vaccination drive and achieving the 75-crore mark.

“WHO congratulates India for scaling up Covid-19 vaccination at an unprecedented pace. While it took 85 days to administer first 100 million doses, India reached 750 million doses from 650 million in just 13 days,” Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said. PTI INSIDE FLAP

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India